1 |
El-Dars LD, Statham BN, Blackford S, Williams N. Lymphocytoma cutis treated with topical tacrolimus. Clin Exp Dermatol 2005;30:305-7.
DOI
|
2 |
Mikasa K, Watanabe D, Kondo C, Tamada Y, Matsumoto Y. Topical 5-aminolevulinic acid-based photodynamic therapy for the treatment of a patient with cutaneous pseudolymphoma. J Am Acad Dermatol 2005;53:911-2.
DOI
|
3 |
Arai E, Shimizu M, Tsuchida T, Izaki S, Ogawa F, Hirose T. Lymphomatoid keratosis: an epidermotropic type of cutaneous lymphoid hyperplasia: clinicopathological, immunohistochemical, and molecular biological study of 6 cases. Arch Dermatol 2007;143:53-9.
|
4 |
Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Fitzpatrick's dermatology in general medicine. 7th ed. New York: McGraw-Hill; 2008:1407-8.
|
5 |
Salama S. Primary cutaneous B-cell lymphoma and lymphoproliferative disorders of skin: current status of pathology and classification. Am J Clin Pathol 2000;114 Suppl:S104-28.
|
6 |
Takeda H, Kaneko T, Harada K, Matsuzaki Y, Nakano H, Hanada K. Successful treatment of lymphadenosis benigna cutis with topical photodynamic therapy with delta-aminolevulinic acid. Dermatology 2005;211:264-6.
DOI
|
7 |
McElroy MK, Kulidjian AA, Sumit R, Weidner N. Benign lymphoid hyperplasia (pseudolymphoma) of soft tissue. Hum Pathol 2011;42:1813-8.
DOI
|
8 |
Schartz NE, De La Blanchardiere A, Alaoui S, Morel P, Sigaux F, Vignon-Pennamen MD, et al. Regression of CD8+ pseudolymphoma after HIV antiviral triple therapy. J Am Acad Dermatol 2003;49:139-41.
|